rhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU.

Nitrosoureas are the drugs most effective in the treatment of patients with intracerebral malignant glioma. Their limiting toxicity is delayed myelosuppression. A prospective, randomised crossover study of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) was performed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rampling, R., Steward, W., Paul, J., Macham, M. A., Harvey, E., Eckley, D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968853/
https://www.ncbi.nlm.nih.gov/pubmed/8123485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968853/
https://www.ncbi.nlm.nih.gov/pubmed/8123485

Ejemplares similares